Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ) - Malmstrom, A (J Clin Oncol 2010, ASCO Annual Meeting Proceedings (Post-Meeting Edition))
18s, LBA2002.